However, novel biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), Cystatin C, IGFBP7, and osteopontin, as reliable measurement tools for detecting AKI have shown promising results [49–52]. This evidence concerns the gene IGFBP7 and acute kidney injury.